|
|
|
Three Months Ended June 30 |
|
|
|
|
Cumulative Foreign
Currency Translation
Adjustments |
|
Net Actuarial
Losses and Prior
Service Costs and
Credits |
|
Cumulative
Unrealized Gains
on Marketable
Equity Securities |
|
Cumulative Gains
on Derivative
Instruments
Designated as Cash
Flow Hedges |
|
|
(in millions) |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
|
Balance at March 31 (a) |
|
$ |
(656 |
) |
$ |
(777 |
) |
$ |
(1,296 |
) |
$ |
(2,186 |
) |
$ |
13 |
|
$ |
32 |
|
$ |
5 |
|
$ |
38 |
|
|
Other comprehensive income (loss) before Reclassifications |
|
(19 |
) |
(360 |
) |
— |
|
— |
|
1 |
|
7 |
|
— |
|
12 |
|
|
Amounts reclassified from accumulated other comprehensive income (b) |
|
— |
|
— |
|
12 |
|
28 |
|
(5 |
) |
(5 |
) |
(7 |
) |
(15 |
) |
|
Net current period comprehensive income from continuing operations |
|
(19 |
) |
(360 |
) |
12 |
|
28 |
|
(4 |
) |
2 |
|
(7 |
) |
(3 |
) |
|
Balance at June 30 (a) |
|
$ |
(675 |
) |
$ |
(1,137 |
) |
$ |
(1,284 |
) |
$ |
(2,158 |
) |
$ |
9 |
|
$ |
34 |
|
$ |
(2 |
) |
$ |
35 |
|
|
|
|
Six Months Ended June 30 |
|
|
|
|
Cumulative Foreign
Currency Translation
Adjustments |
|
Net Actuarial
Losses and Prior
Service Costs and
Credits |
|
Cumulative
Unrealized Gains
on Marketable
Equity Securities |
|
Cumulative Gains
on Derivative
Instruments
Designated as Cash
Flow Hedges |
|
|
(in millions) |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
|
Balance at December 31, 2013 and 2012 |
|
$ |
(718 |
) |
$ |
(79 |
) |
$ |
(1,312 |
) |
$ |
(3,596 |
) |
$ |
13 |
|
$ |
31 |
|
$ |
5 |
|
$ |
50 |
|
|
Separation of AbbVie (a) |
|
— |
|
(308 |
) |
— |
|
1,451 |
|
— |
|
— |
|
— |
|
8 |
|
|
Other comprehensive income (loss) before Reclassifications |
|
43 |
|
(750 |
) |
— |
|
(69 |
) |
2 |
|
14 |
|
(1 |
) |
(5 |
) |
|
Amounts reclassified from accumulated other comprehensive income (b) |
|
— |
|
— |
|
28 |
|
56 |
|
(6 |
) |
(11 |
) |
(6 |
) |
(18 |
) |
|
Net current period comprehensive income from continuing operations (a) |
|
43 |
|
(750 |
) |
28 |
|
(13 |
) |
(4 |
) |
3 |
|
(7 |
) |
(23 |
) |
|
Balance at June 30 |
|
$ |
(675 |
) |
$ |
(1,137 |
) |
$ |
(1,284 |
) |
$ |
(2,158 |
) |
$ |
9 |
|
$ |
34 |
|
$ |
(2 |
) |
$ |
35 |
|
(a) Prior year amounts have been appropriately revised to reflect a reclassification between Cumulative foreign currency translation adjustment and Net actuarial losses and prior service costs and credits.
(b) Reclassified amounts for foreign currency translation are recorded in the Condensed Consolidated Statement of Earnings as Net foreign exchange loss (gain); gains on marketable equity securities as Other (income) expense, net and cash flow hedges as Cost of products sold. Net actuarial losses and prior service cost is included as a component of net periodic benefit plan costs; see Note 11 for additional details.
|